CD86 and neoplasm: Macrophage colony-stimulating factor (M-CSF), TGF-β, and vascular endothelial growth factor (VEGF) from primary tumor supernatants of breast cancer-induced healthy donor blood monocytes to differentiate into CD163-high CD86-low IL-10-high M2-like macrophages [78].